News and Trends 28 Apr 2023ADC firm Adcentrx Therapeutics aims for clinic after $38M boost Antibody-drug conjugate (ADC) biotech company Adcentrx Therapeutics has closed a $38 million Series A+ financing. The round was led by… April 28, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email